The Possibilities of Tomorrow: New Blood Test for Early Detection of Alzheimer’s with Dr. Joel Braunstein

alzheimer’s blood tests brain brain activities cognitive detection disease early detection health health talks intellectual medicine plaque precivity test prevention research treatment Nov 04, 2021
 

As we continue to talk about Alzheimer’s disease, technological advancements have allowed physicians to detect early signs of this disease. Autopsies, brain scans, and blood tests paved the way for physicians to finally identify cognitive disorders more accurately and thoroughly in a shorter span of time. 

Due to a lack of resources and know-how, the medical community used to focus only on treating sickness and disease instead of being proactive in the field of prevention. But as we are able to explore and discover new procedures and medical solutions to prevent future illnesses and complications, we have not only saved lives but have made good use of our resources as well.

As we’ve discussed Cognivue and Aduhelm from the previous episodes, a new blood test called, “PrecivityAD™ test”, has been developed for patients with cognitive impairment and for those who are displaying early memory and thinking problems. This test help physicians to indirectly determine the presence of beta-amyloid plaques in the brain by measuring this biomarker in the blood. Listen to Episode 8 as Dr. Dung Trinh is joined by our guest,  Dr. Joel Braunstein, as they discuss this simple method to detect Alzheimer’s early on and the benefits this test can offer.

Gain relevant information about the PrecivityAD test and how this can greatly help the medical field when you listen to Episode 8! 

Memorable Quotes:

  • Just because someone has a genetic risk factor does not guarantee that they will get the disease. - Dr. Joel Braunstein
  • 40 percent of dementia cognitive decline can be modifiable through lifestyle changes. - Dr. Joel Braunstein
  • Sleep is super important to allow your brain to rest. - Dr. Joel Braunstein

Other Resources:

Important Points:

  • Mass spectrometry is used to measure the atomic weight of particles that are circulating in the brain, blood, and CSL. 
  • A blood test can potentially replace a more invasive and more expensive brain scan.
  • Having the beta amyloid plaque in the brain doesn’t condemn you to the diagnosis of having Alzheimer’s
  • The "Six Pillars" to stimulate your brain and reduce the risk for Alzheimer’s: physical exercise, brain exercise, socialization, getting enough sleep, controlling other health conditions, and nutrition.

About the Guests:

Joel Braunstein, MD, MBA is the CEO and Co-founder of C2N Diagnostics, CEO of LifeTech Research, and founding CEO of Tivorsan Pharmaceuticals. Click here for more information about the guest.

About the Host:

Dung Trinh, MD is the Chief Medical Officer of Irvine Clinical Research, medical missionary with TongueOut Medical Missions, and holds leadership positions with multiple health care organizations in Orange County. He is a keynote speaker, best-selling author, and Host of “Health Talks with Dr. Trinh” which can be heard weekly on OC Talk Radio.

Connect with Dr. Trinh

Want your own copy of Dr. Trinh's amazing book on Alzheimer's?   

Get your own copy of Alzheimer's: What You Need To Know (And Why You Should Care) by Dr. Dung Trinh.

For every patient officially diagnosed with Alzheimer’s, many more are living with this condition undiagnosed. Stay on top of this cognitive condition by knowing the symptoms and risk reduction strategies.

Spoiler Alert: It's so good you can't put it down.